Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Given Average Recommendation of “Moderate Buy” by Analysts
Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the ten research firms that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and eight have given a buy […]
8 Sep 04:45 · The Cerbat Gem